SlideShare a Scribd company logo
1 of 1
Download to read offline
what is
REGULATORY SCIENCE?
According to the Food and Drug
Administration (FDA), regulatory science
is the science of developing new tools,
standards, and approaches to assess the
safety, efficacy, quality, and performance of
FDA-regulated products.
Five Courses, Part-Time,
TWO YEARS
The MS in Regulatory Science
degree is earned through successful
completion of five online courses in as little
as two years. In each course, students are
assessed via projects, online presentations,
and mini-reviews.
Five Semesters
Drug, Biologic, and Device Regulation (6
credits) Fall Semester
Drug Discovery (6 credits) Spring Semester
Drug and Biologics Development (6 credits)
Summer Semester
Clinical Research (6 credits) Fall Semester
Regulated Products in the Marketplace (6
credits) Spring Semester
Who Should APPLY?
This online program is primarily designed
for working professionals with Bachelor of
Science (BS) degrees who now work in (or
would like to work in) regulatory science at
government agencies or in industry.
Potential students include:
•	 Regulatory affairs associates
•	 Scientists in research or development
•	 Clinical associates in clinical affairs or
marketed-product support
•	 Associates in pharmacovigilance and
Phase IV research
CONTACT
MS in Regulatory Science
University of Maryland
School of Pharmacy
20 Penn Street, HSFII, Room 503B
Baltimore, MD 21201
Phone: 410-706-7241
regsci@rx.umaryland.edu
The Master of Science
(MS) in Regulatory Science
program at the University
of Maryland School of
Pharmacy is a part-time
program, exclusively online -
no classroom required.
The MS in Regulatory Science is a science-
driven program focused on drug product development and regulation, including aspects
of biologics, diagnostics, devices, nutritional products, and worldwide regulatory
principles.
The program utilizes asynchronous (i.e. pre-recorded) lectures, web conferencing, and
online active-learning instruction. In addition to virtual learning students will have the
ability to interact with faculty, peers, and their personal industrial regulatory scientist
mentor.
Build your regulatory science portfolio!
A graduate of the MS in Regulatory Science program will be able to:
•	 Devise and implement global strategies for drug, biologic, and device development
and evaluation
•	 Differentiate United States and other regional requirements for drug product
development and registration
•	 Apply principles of basic and applied pharmaceutical sciences in drug discovery and
development
•	 Formulate critical elements of chemistry, manufacturing, and controls (CMC) to drug
development
•	 Relate principles of clinical research design to practices in clinical trial management
•	 Apply critical elements of risk and utilization to post-marketing surveillance and
pharmacoepidemiology, and evaluate economic and human factors that impact
drug use
CAREERS in Regulatory Science
With the knowledge and skills obtained through this program, graduates will have
access to a number of career opportunities in drug research and development, including
but not limited to:
•	 Regulatory science/affairs positions at pharmaceutical companies, as well as device
and biotechnology companies
•	 Regulatory science/affairs positions at government agencies, such as the Food
and Drug Administration (FDA), National Institutes of Health (NIH), Department
of Defense, Biomedical Advanced Research and Development Authority, and the
Centers for Disease Control (CDC)
•	 Admission into PhD programs
CENTER OF EXCELLENCE IN REGULATORY
SCIENCE AND INNOVATION
The MS in Regulatory Science is complemented by the University of Maryland’s Center
of Excellence in Regulatory Science and Innovation (CERSI). CERSI is funded by the U.S.
Food and Drug Administration (FDA). University researchers work with FDA staff to
support the development of new tools, standards, and approaches to assess the safety,
efficacy, quality, and performance of FDA-regulated products.
For information about the University of Maryland’s collaboration with FDA, and CERSI
regulatory science research, training, and exchange, visit www.cersi.umd.edu.
Master of Science in
REGULATORY SCIENCE
pharmacy.umaryland.edu/RegulatoryScience

More Related Content

What's hot

Outsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract researchOutsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract research
Gauravchaudhary199
 

What's hot (20)

Therapeutic Goods Evaluation Panel Roadshow - Overview of Toxicology Evaluation
Therapeutic Goods Evaluation Panel Roadshow - Overview of Toxicology Evaluation Therapeutic Goods Evaluation Panel Roadshow - Overview of Toxicology Evaluation
Therapeutic Goods Evaluation Panel Roadshow - Overview of Toxicology Evaluation
 
Therapeutic Goods Evaluation Panel Roadshow - Overview of Chemistry Evaluations
Therapeutic Goods Evaluation Panel Roadshow - Overview of Chemistry EvaluationsTherapeutic Goods Evaluation Panel Roadshow - Overview of Chemistry Evaluations
Therapeutic Goods Evaluation Panel Roadshow - Overview of Chemistry Evaluations
 
Pharmacovigilance (gpv p) training in india
Pharmacovigilance (gpv p) training in india Pharmacovigilance (gpv p) training in india
Pharmacovigilance (gpv p) training in india
 
What Can You Do at the UNC Eshelman School of Pharmacy
What Can You Do at the UNC Eshelman School of PharmacyWhat Can You Do at the UNC Eshelman School of Pharmacy
What Can You Do at the UNC Eshelman School of Pharmacy
 
Biomarker validation and testing
Biomarker validation and testingBiomarker validation and testing
Biomarker validation and testing
 
Outsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract researchOutsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract research
 
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
 
Why pharmacovigilance
Why pharmacovigilanceWhy pharmacovigilance
Why pharmacovigilance
 
Careers In Clinical Research
Careers In Clinical ResearchCareers In Clinical Research
Careers In Clinical Research
 
STREAM TWO: Larissa Lapteva, Medical Product Development For Rare Diseases Pa...
STREAM TWO: Larissa Lapteva, Medical Product Development For Rare Diseases Pa...STREAM TWO: Larissa Lapteva, Medical Product Development For Rare Diseases Pa...
STREAM TWO: Larissa Lapteva, Medical Product Development For Rare Diseases Pa...
 
Late Phase Outsourcing - Clinical Studies
Late Phase Outsourcing - Clinical StudiesLate Phase Outsourcing - Clinical Studies
Late Phase Outsourcing - Clinical Studies
 
Esssential documnets in clinical trial
Esssential documnets in clinical trialEsssential documnets in clinical trial
Esssential documnets in clinical trial
 
Career in clinical research
Career in clinical researchCareer in clinical research
Career in clinical research
 
Law update, march 2011
Law update, march 2011Law update, march 2011
Law update, march 2011
 
201709 phacilitate atmp_nc_perspectives_cecile r_slide_share
201709 phacilitate atmp_nc_perspectives_cecile r_slide_share201709 phacilitate atmp_nc_perspectives_cecile r_slide_share
201709 phacilitate atmp_nc_perspectives_cecile r_slide_share
 
Significance of pharmacovigilance in clinical research courses ppt
Significance of pharmacovigilance in clinical research courses pptSignificance of pharmacovigilance in clinical research courses ppt
Significance of pharmacovigilance in clinical research courses ppt
 
Career in clinical research
Career in clinical researchCareer in clinical research
Career in clinical research
 
Clinical research
Clinical researchClinical research
Clinical research
 
UNC Eshelman School of Pharmacy Highlights
UNC Eshelman School of Pharmacy HighlightsUNC Eshelman School of Pharmacy Highlights
UNC Eshelman School of Pharmacy Highlights
 
Clinical research coordinator responsibilities
Clinical research coordinator responsibilitiesClinical research coordinator responsibilities
Clinical research coordinator responsibilities
 

Viewers also liked

Klöckner & Co - Baader Bank AG, Baader Investment Conference, September 24, 2013
Klöckner & Co - Baader Bank AG, Baader Investment Conference, September 24, 2013Klöckner & Co - Baader Bank AG, Baader Investment Conference, September 24, 2013
Klöckner & Co - Baader Bank AG, Baader Investment Conference, September 24, 2013
Klöckner & Co SE
 
Curriculum Vitae pro
Curriculum Vitae proCurriculum Vitae pro
Curriculum Vitae pro
Prosper Ntuli
 
El baz11 gsasp483-training_apolloast
El baz11 gsasp483-training_apolloastEl baz11 gsasp483-training_apolloast
El baz11 gsasp483-training_apolloast
Sérgio Sacani
 
Universidad autonoma de chihuahuaEvolución de la comunicación humana por medi...
Universidad autonoma de chihuahuaEvolución de la comunicación humana por medi...Universidad autonoma de chihuahuaEvolución de la comunicación humana por medi...
Universidad autonoma de chihuahuaEvolución de la comunicación humana por medi...
Alan Almn
 
Capacidades sector salud iti
Capacidades sector salud  itiCapacidades sector salud  iti
Capacidades sector salud iti
Redit
 

Viewers also liked (20)

Klöckner & Co - Baader Bank AG, Baader Investment Conference, September 24, 2013
Klöckner & Co - Baader Bank AG, Baader Investment Conference, September 24, 2013Klöckner & Co - Baader Bank AG, Baader Investment Conference, September 24, 2013
Klöckner & Co - Baader Bank AG, Baader Investment Conference, September 24, 2013
 
Curriculum Vitae pro
Curriculum Vitae proCurriculum Vitae pro
Curriculum Vitae pro
 
commons
commonscommons
commons
 
Formato hoja vida_2011
Formato hoja vida_2011Formato hoja vida_2011
Formato hoja vida_2011
 
Cortland warrior rugby
Cortland warrior rugbyCortland warrior rugby
Cortland warrior rugby
 
07. TIPOS DE UNIONES EN SOLDEO ELÉCTRICO.
07.  TIPOS DE UNIONES EN SOLDEO ELÉCTRICO.07.  TIPOS DE UNIONES EN SOLDEO ELÉCTRICO.
07. TIPOS DE UNIONES EN SOLDEO ELÉCTRICO.
 
Prog iau09
Prog iau09Prog iau09
Prog iau09
 
Noah's brochure
Noah's brochureNoah's brochure
Noah's brochure
 
Revista Triodos Nº 19
Revista Triodos Nº 19Revista Triodos Nº 19
Revista Triodos Nº 19
 
David herrera
David herreraDavid herrera
David herrera
 
El baz11 gsasp483-training_apolloast
El baz11 gsasp483-training_apolloastEl baz11 gsasp483-training_apolloast
El baz11 gsasp483-training_apolloast
 
Jóvenes Rurales - Estrategias digitales: Una oportunidad a la vista
Jóvenes Rurales - Estrategias digitales: Una oportunidad a la vistaJóvenes Rurales - Estrategias digitales: Una oportunidad a la vista
Jóvenes Rurales - Estrategias digitales: Una oportunidad a la vista
 
Universidad autonoma de chihuahuaEvolución de la comunicación humana por medi...
Universidad autonoma de chihuahuaEvolución de la comunicación humana por medi...Universidad autonoma de chihuahuaEvolución de la comunicación humana por medi...
Universidad autonoma de chihuahuaEvolución de la comunicación humana por medi...
 
Appendices - Draft RiverFIRST Proposal
Appendices - Draft RiverFIRST ProposalAppendices - Draft RiverFIRST Proposal
Appendices - Draft RiverFIRST Proposal
 
Administración pública y la ciudadanía: caso del municipio de Patzún
Administración pública y la ciudadanía: caso del municipio de PatzúnAdministración pública y la ciudadanía: caso del municipio de Patzún
Administración pública y la ciudadanía: caso del municipio de Patzún
 
Capacidades sector salud iti
Capacidades sector salud  itiCapacidades sector salud  iti
Capacidades sector salud iti
 
Operadores cedeu
Operadores cedeuOperadores cedeu
Operadores cedeu
 
ieudla BLAVING
ieudla BLAVINGieudla BLAVING
ieudla BLAVING
 
2008 - Gewinnung von OPEN SOURCE Techniken für junge Unternehmen
2008 - Gewinnung von OPEN SOURCE Techniken für junge Unternehmen2008 - Gewinnung von OPEN SOURCE Techniken für junge Unternehmen
2008 - Gewinnung von OPEN SOURCE Techniken für junge Unternehmen
 
Cepist folder
Cepist folderCepist folder
Cepist folder
 

Similar to MS_Reg Sci One Page Flyer 2014-2015

Clinical trials research and administration
Clinical trials research and administrationClinical trials research and administration
Clinical trials research and administration
BII Noida
 
1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx
MdJubair13
 

Similar to MS_Reg Sci One Page Flyer 2014-2015 (20)

Product type- Drug development - Departments of facility- Registration pathwa...
Product type- Drug development - Departments of facility- Registration pathwa...Product type- Drug development - Departments of facility- Registration pathwa...
Product type- Drug development - Departments of facility- Registration pathwa...
 
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
 
Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development
 
Resume
ResumeResume
Resume
 
Best Clinical Research Courses In India 2023-2024.pdf
Best Clinical Research Courses In India 2023-2024.pdfBest Clinical Research Courses In India 2023-2024.pdf
Best Clinical Research Courses In India 2023-2024.pdf
 
Do you know how many rewarding job opportunities exist in the Clinical resea...
Do you know how many rewarding  job opportunities exist in the Clinical resea...Do you know how many rewarding  job opportunities exist in the Clinical resea...
Do you know how many rewarding job opportunities exist in the Clinical resea...
 
Creating a Comprehensive Drug Development Plan
Creating a Comprehensive Drug Development PlanCreating a Comprehensive Drug Development Plan
Creating a Comprehensive Drug Development Plan
 
Pharmaceutical programs Canada
Pharmaceutical programs   CanadaPharmaceutical programs   Canada
Pharmaceutical programs Canada
 
planning and initiation.pptx
planning and initiation.pptxplanning and initiation.pptx
planning and initiation.pptx
 
Clinical Pharmacology: Leveraging Science to Provide Access
Clinical Pharmacology: Leveraging Science to Provide AccessClinical Pharmacology: Leveraging Science to Provide Access
Clinical Pharmacology: Leveraging Science to Provide Access
 
Career Opportunities in the Clinical Research Industry
Career Opportunities in the Clinical Research IndustryCareer Opportunities in the Clinical Research Industry
Career Opportunities in the Clinical Research Industry
 
How clinical research courses can help you in securing your future
How clinical research courses can help you in securing your futureHow clinical research courses can help you in securing your future
How clinical research courses can help you in securing your future
 
Get Your Development Program Started on the Right Foot
Get Your Development Program Started on the Right FootGet Your Development Program Started on the Right Foot
Get Your Development Program Started on the Right Foot
 
201 regulatory aspects of drug and cosmetics .pdf
201 regulatory aspects of drug and cosmetics .pdf201 regulatory aspects of drug and cosmetics .pdf
201 regulatory aspects of drug and cosmetics .pdf
 
pc15098_brochure
pc15098_brochurepc15098_brochure
pc15098_brochure
 
Resume
ResumeResume
Resume
 
Pharmacy - education & career in healthcare.
Pharmacy  - education & career in healthcare.Pharmacy  - education & career in healthcare.
Pharmacy - education & career in healthcare.
 
regulatory requirements for drug approval ( IP-2 / UNIT -3 )
regulatory requirements for drug approval ( IP-2  / UNIT -3 )regulatory requirements for drug approval ( IP-2  / UNIT -3 )
regulatory requirements for drug approval ( IP-2 / UNIT -3 )
 
Clinical trials research and administration
Clinical trials research and administrationClinical trials research and administration
Clinical trials research and administration
 
1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx
 

MS_Reg Sci One Page Flyer 2014-2015

  • 1. what is REGULATORY SCIENCE? According to the Food and Drug Administration (FDA), regulatory science is the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products. Five Courses, Part-Time, TWO YEARS The MS in Regulatory Science degree is earned through successful completion of five online courses in as little as two years. In each course, students are assessed via projects, online presentations, and mini-reviews. Five Semesters Drug, Biologic, and Device Regulation (6 credits) Fall Semester Drug Discovery (6 credits) Spring Semester Drug and Biologics Development (6 credits) Summer Semester Clinical Research (6 credits) Fall Semester Regulated Products in the Marketplace (6 credits) Spring Semester Who Should APPLY? This online program is primarily designed for working professionals with Bachelor of Science (BS) degrees who now work in (or would like to work in) regulatory science at government agencies or in industry. Potential students include: • Regulatory affairs associates • Scientists in research or development • Clinical associates in clinical affairs or marketed-product support • Associates in pharmacovigilance and Phase IV research CONTACT MS in Regulatory Science University of Maryland School of Pharmacy 20 Penn Street, HSFII, Room 503B Baltimore, MD 21201 Phone: 410-706-7241 regsci@rx.umaryland.edu The Master of Science (MS) in Regulatory Science program at the University of Maryland School of Pharmacy is a part-time program, exclusively online - no classroom required. The MS in Regulatory Science is a science- driven program focused on drug product development and regulation, including aspects of biologics, diagnostics, devices, nutritional products, and worldwide regulatory principles. The program utilizes asynchronous (i.e. pre-recorded) lectures, web conferencing, and online active-learning instruction. In addition to virtual learning students will have the ability to interact with faculty, peers, and their personal industrial regulatory scientist mentor. Build your regulatory science portfolio! A graduate of the MS in Regulatory Science program will be able to: • Devise and implement global strategies for drug, biologic, and device development and evaluation • Differentiate United States and other regional requirements for drug product development and registration • Apply principles of basic and applied pharmaceutical sciences in drug discovery and development • Formulate critical elements of chemistry, manufacturing, and controls (CMC) to drug development • Relate principles of clinical research design to practices in clinical trial management • Apply critical elements of risk and utilization to post-marketing surveillance and pharmacoepidemiology, and evaluate economic and human factors that impact drug use CAREERS in Regulatory Science With the knowledge and skills obtained through this program, graduates will have access to a number of career opportunities in drug research and development, including but not limited to: • Regulatory science/affairs positions at pharmaceutical companies, as well as device and biotechnology companies • Regulatory science/affairs positions at government agencies, such as the Food and Drug Administration (FDA), National Institutes of Health (NIH), Department of Defense, Biomedical Advanced Research and Development Authority, and the Centers for Disease Control (CDC) • Admission into PhD programs CENTER OF EXCELLENCE IN REGULATORY SCIENCE AND INNOVATION The MS in Regulatory Science is complemented by the University of Maryland’s Center of Excellence in Regulatory Science and Innovation (CERSI). CERSI is funded by the U.S. Food and Drug Administration (FDA). University researchers work with FDA staff to support the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products. For information about the University of Maryland’s collaboration with FDA, and CERSI regulatory science research, training, and exchange, visit www.cersi.umd.edu. Master of Science in REGULATORY SCIENCE pharmacy.umaryland.edu/RegulatoryScience